H19 activates Wnt signaling and promotes osteoblast differentiation by functioning as a competing endogenous RNA
2016 · Scientific Reports · 253 citations
https://doi.org/10.1038/srep20121
L
Liangliang Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
169
Papers
4.9K
Citations
41
h-index
92
i10-index
Liangliang Xu is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Mesenchymal stem cell research & Bone Metabolism and Diseases & MicroRNA in disease regulation. The author has an h-index of 41, co-authored 144 publications.
ORCID: 0000-0002-5249-7480Papers by this author
worksAn improved protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow
2014 · Journal of Orthopaedic Translation · 225 citations
https://doi.org/10.1016/j.jot.2014.07.005
Circulating mesenchymal stem cells and their clinical implications
2013 · Journal of Orthopaedic Translation · 76 citations
https://doi.org/10.1016/j.jot.2013.11.002
MiR-503 Promotes Bone Formation in Distraction Osteogenesis through Suppressing Smurf1 Expression
2017 · Scientific Reports · 71 citations
https://doi.org/10.1038/s41598-017-00466-4
Tauroursodeoxycholic acid alleviates secondary injury in spinal cord injury mice by reducing oxidative stress, apoptosis, and inflammatory response
2021 · Journal of Neuroinflammation · 71 citations
https://doi.org/10.1186/s12974-021-02248-2
DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer
2014 · Oncogene · 60 citations
https://doi.org/10.1038/onc.2014.201
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat